KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iqvia Holdings (IQV) Cash & Equivalents (2016 - 2025)

Iqvia Holdings (IQV) has disclosed Cash & Equivalents for 15 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 16.33% to $2.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2025, up 16.33% year-over-year, with the annual reading at $2.0 billion for FY2025, 16.33% up from the prior year.
  • Cash & Equivalents hit $2.0 billion in Q4 2025 for Iqvia Holdings, up from $1.8 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.3 billion in Q1 2021 to a low of $1.2 billion in Q4 2022.
  • Historically, Cash & Equivalents has averaged $1.6 billion across 5 years, with a median of $1.5 billion in 2021.
  • Biggest five-year swings in Cash & Equivalents: soared 148.65% in 2021 and later crashed 39.83% in 2022.
  • Year by year, Cash & Equivalents stood at $1.4 billion in 2021, then dropped by 10.98% to $1.2 billion in 2022, then increased by 13.16% to $1.4 billion in 2023, then increased by 23.69% to $1.7 billion in 2024, then rose by 16.33% to $2.0 billion in 2025.
  • Business Quant data shows Cash & Equivalents for IQV at $2.0 billion in Q4 2025, $1.8 billion in Q3 2025, and $2.0 billion in Q2 2025.